China's stuttering recovery darkens global corporate growth outlook
By Medha Singh
Aug 2 (Reuters) -Global burger chains to car manufacturers are increasingly feeling the pinch from a faltering recovery in the world's No. 2 economy, China, and are strapping in for a bumpy ride ahead.
A protracted downturn in the property market and high levels of job insecurity have knocked the wind out of a fragile recovery in China, a global trading powerhouse, and the effects of its slowdown can be felt across borders.
Coffee chain Starbucks SBUX.O, carmaker General Motors GM.N and technology firms hurt by curbs on exports to China are among those that have sounded the alarm on weakness in the nation. The Chinese government's stimulus measures have so far failed to boost consumption, and the overleveraged property market has made consumers less likely to spend.
"It's a difficult market right now. And frankly, it's unsustainable, because the amount of companies losing money there cannot continue indefinitely," General Motors CEO Mary Barra said last week as the automaker's division in China shifted from being a profit engine to a drain on its finances.
China's $18.6 trillion economy grew more slowly than expected in the second quarter, and cautious households are building up savings and paying off debts. Retail sales growth sank to an 18-month low in June, and businesses cut prices on everything from cars to food to clothes.
In a bid to stem the rot, China outlined stimulus directed at consumers last month to support equipment upgrades and consumer goods trade-ins, but that has not allayed concerns.
Some analysts have warned that barring a structural shift that gives consumers a greater role in the economy, the current path fuels risks of a prolonged period of near-stagnation and persistent deflation threats.
"There is a deep concern that Beijing is not introducing the kind of stimulus that helps broaden the economic base," said Quincy Krosby, chief global strategist for LPL Financial.
"It's becoming more difficult for U.S. companies to look to the Chinese market as a reliable partner."
China remained a drag on Apple AAPL.O last quarter. The iPhone maker's sales declined a much steeper-than-expected 6.5% in the country, which accounts for a fifth of its total revenue.
French cosmetics giant L'Oreal OREP.PA said the Chinese beauty market will remain slightly negative into the second half of 2024 with no visible improvement in sentiment.
Other consumer companies' sales have been hurt as well, including Starbucks SBUX.O, McDonald's MCD.N and Procter & Gamble PG.N, while soft domestic travel demand prompted a revenue warning from Marriott MAR.O.
The sluggish growth was also evident in underwhelming results from luxury goods makers LVMH LVMH.PA and Gucci-owner Kering PRTP.PA and profit warnings from Burberry BRBY.L and Hugo Boss BOSSn.DE.
"The world was surprised at how weak China was economically as this year unfolded," said Marc Casper, CEO of medical equipment maker Thermo Fisher TMO.N.
Meanwhile, foreign automakers from Tesla TSLA.O to BMW BMWG.DE, Audi and Mercedes MBGn.DE, are locked in an intense price war in China after ceding market share to domestic EV makers, led by BYD 002594.SZ, who offer high-tech, low-cost models.
To be sure, the MSCI World with China Exposure Index .dMIWOC000eNUS, which tracks 52 companies with high revenue exposure to China, is up 11.6% this year, not far off a 12% rise in MSCI's broad gauge of global stocks .MIWD00000PUS.
However, most of the China-focused index's performance is thanks to a surge in semiconductor stocks, including Broadcom AVGO.O and Qualcomm QCOM.O, which have benefited from AI-driven demand.
POLICY CHALLENGES
Mounting Sino-U.S. trade tensions and certain domestic policies have added to multinational companies' woes.
Beijing's anti-corruption campaign that began last year has caused disruptions that partly prompted GE HealthCare GEHC.O to lower its revenue growth forecast and sparked concerns over sales of Merck's MRK.N Gardasil vaccine.
Meanwhile, tighter U.S. export curbs on sharing high-end chip technology with China are impeding chipmakers from serving one of the largest markets for semiconductors.
Qualcomm said it took a revenue hit from the U.S. curbs on exports to China, overshadowing its otherwise upbeat forecast on Wednesday.
Analysts said the pressures are unlikely to ease soon.
"It has been a surprise that (the slowdown) has lasted so long," said Stuart Cole, chief macroeconomist at Equiti Capital.
"Once the Covid restrictions were lifted the general expectation was that China would bounce back. But the Chinese pace of expansion we saw previously will not be seen any time soon."
China's consumer confidence remains low https://reut.rs/3WLgfo5
Companies with significant revenue exposure to China https://reut.rs/3ypLmMJ
Reporting by Medha Singh and Leroy Leo in Bengaluru; additional reporting by Aditya Soni, Juveria Tabassum, Manya Saini, Bhanvi Satija, Seher Dareen, Aby Jose and Yadarisa Shabong; Editing by Arpan Varghese and Anil D'Silva
İlgili varlıklar
En son haberler
Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.
Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.
Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.
